WeVote

Bill

Bill

SB 1621

Establishes provisions relating to civil actions involving medical monitoring

2026 Regular Session Introduced by Kurtis Gregory

SB 1621 creates legal standards for medical monitoring civil claims, defining when courts can order defendants to fund health surveillance for people exposed to hazardous substances.

Second Read and Referred S General Laws Committee
0
WeVote Research Nonpartisan
Bill Summary · SB 1621

Legislative bill overview

SB 1621 establishes legal provisions governing civil actions where plaintiffs seek court-ordered medical monitoring rather than traditional damages for exposure to hazardous substances or medical conditions. The bill creates a framework defining when such claims are permissible, what plaintiffs must prove, and how courts should evaluate these cases.

Why is this important

Medical monitoring claims allow people exposed to toxins or at-risk populations to obtain court-ordered surveillance of their health without proving they've already developed an illness. This affects product liability cases, environmental contamination litigation, and occupational exposure disputes—determining who can sue, under what conditions, and with what remedies available.

Potential points of contention

  • Burden of proof standards: Defining how much medical evidence plaintiffs need to establish that monitoring is reasonable and necessary may either expand access to court remedies or create barriers for vulnerable populations
  • Cost allocation: Determining whether defendants must fund monitoring programs could significantly impact liability exposure for manufacturers, employers, and property owners
  • Threshold requirements: Disputes over how much exposure or risk is sufficient to qualify for monitoring claims could affect which cases proceed to trial versus dismissal

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.